Neuro-oncologie
• EORTC studie 26053-22054, Phase III trial on Concurrent and Adjuvant Temozolomide Chemotherapy in non-1p/19q deleted Anaplastic Glioma. The CATNON intergroup trial
>>> lees verder
• Phase III Intergroup Study of Radiotherapy versus Temozolomide versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal co-deletions of 1p and 19q
>>> lees verder
• A randomized phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
>>> lees verder
• Phase I/II study for patients with newly diagnosed glioblastoma testing nelfinavir in combination with concomitant temozolomide and radiotherapy
>>> lees verder
• Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study
>>> lees verder
• Cognitive Sequelae of Prophylactic Cranial Irradiation in Non-small Cell Lung Cancer Patients
>>>lees verder
>>> lees verder
• Phase III Intergroup Study of Radiotherapy versus Temozolomide versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal co-deletions of 1p and 19q
>>> lees verder
• A randomized phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
>>> lees verder
• Phase I/II study for patients with newly diagnosed glioblastoma testing nelfinavir in combination with concomitant temozolomide and radiotherapy
>>> lees verder
• Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study
>>> lees verder
• Cognitive Sequelae of Prophylactic Cranial Irradiation in Non-small Cell Lung Cancer Patients
>>>lees verder